Abstract
We describe a 69-year-old patient with long-standing mixed connective tissue disease who suffered from severe skin eruptions that did not respond to various immunosuppressive regimens. Therapy with high-dose intravenous immunoglobulin was successful in controlling the patient's disease without major side effects. We think that this regimen-although expensive-might be an interesting therapeutic option in selected patients with mixed connective tissue disease that is refractory to other treatment modalities.
MeSH terms
-
Aged
-
Facial Dermatoses / complications
-
Facial Dermatoses / drug therapy
-
Facial Dermatoses / pathology
-
Female
-
Hand Dermatoses / complications
-
Hand Dermatoses / drug therapy
-
Hand Dermatoses / pathology
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage
-
Immunoglobulins, Intravenous / therapeutic use*
-
Mixed Connective Tissue Disease / complications
-
Mixed Connective Tissue Disease / drug therapy*
-
Mixed Connective Tissue Disease / pathology
-
Pulse Therapy, Drug
-
Raynaud Disease / complications
Substances
-
Immunoglobulins, Intravenous